Form 4: Agenus Inc. CEO Garo Armen Receives Stock in Lieu of Cash Salary

Agenus Inc. CEO Garo Armen received 1,248 shares of common stock as payment for his salary for the pay period ending May 3, 2024, as part of an arrangement approved by the company's Compensation Committee.

Summary

• Garo H. Armen, CEO of Agenus Inc., received 1,248 shares of Agenus common stock on May 3, 2024, as salary payment in lieu of cash.
• The stock was issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive plan and was fully vested upon issuance.
• The price of the stock was $13.07 per share, which was the closing price of Agenus common stock on May 3, 2024.
• Following the transaction, Armen directly owns 71,045 shares of Agenus common stock.
• Armen also indirectly owns 31,298 shares through his IRA accounts and 28,950 shares as trustee and general partner of Pixie Partners.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The CEO taking salary in stock suggests confidence, but it's a routine transaction.

Positives

• The CEO's decision to take salary in stock demonstrates confidence in the company's future.
• The stock-based compensation aligns the CEO's interests with those of the shareholders.

Industry Context

Stock-based compensation is a common practice for aligning executive incentives with shareholder value in the biotechnology industry.

Comparison to Industry Standards

• Many biotech companies use stock options and restricted stock units as part of their executive compensation packages.
• The specific amount and vesting schedule can vary widely based on company size, performance, and industry benchmarks.
• Comparing Agenus's executive compensation structure to companies like Immunomedics (prior to acquisition by Gilead), or smaller biotechs like Iovance Biotherapeutics, could provide a relevant benchmark.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the CEO's interests with theirs.
• Employees may view the CEO's decision to take stock as a sign of confidence in the company's future.

Key Dates